1 / 3

Approval of Lenvatinib as a therapy medication for Advanced Kidney Cancer

https://www.cancercurepharmacy.com/BlogDetails.aspx?Title=Approval-of-Lenvatinib-as-a-therapy-medication-for-Advanced-Kidney-Cancer<br><br>Lenvatinib commonly known as Lenvima (manufactured by Eisai), was approved by US Food and Drug Administration in 2016 for the treatment of advanced kidney cancer. This medication has been approved solely for the patients whose cancer has progressed even after receiving treatment from medications which block the tumour growth. Lenvima is classified under the category of targeted therapy. The main aim of the medication which comes under this category is to target something specific to the cancer cells. Thus leading to fewer side effects caused by damage to healthy cells.

Asukasoi
Download Presentation

Approval of Lenvatinib as a therapy medication for Advanced Kidney Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. • •

  2. • • ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓

More Related